²é¿´: 1892  |  »Ø¸´: 5

Áîºü³å?ÛСÐÜ

ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)

ħµÀÊ¥¾ý

[½»Á÷] ¡¾2015ÄêFDAÅú×¼ÐÂÒ©»ã×Ü¡¿ ÒÑÓÐ4È˲ÎÓë

FDA Approved new Drugs in 2015


                                                                                                                                                                           date time£º2015-2-10
Cardiology/Vascular Diseases
Prestalia (perindopril arginine and amlodipine besylate); Symplmed Pharmaceuticals; For the treatment of hypertension, Approved January 2015

Savaysa (edoxaban); Daiichi Sankyo; For the treatment of deep vein thrombosis, pulmonary embolism and risk of stroke and embolism due to atrial fibrillation, Approved January 2015

Dermatology
Cosentyx (secukinumab); Novartis; For the treatment of plaque psoriasis, Approved January 2015

Endocrinology
Natpara (parathyroid hormone) ; NPS Pharmaceuticals; For the control hypocalcemia in patients with hypoparathyroidism, Approved January 2015

Family Medicine
Cosentyx (secukinumab); Novartis; For the treatment of plaque psoriasis, Approved January 2015

Savaysa (edoxaban); Daiichi Sankyo; For the treatment of deep vein thrombosis, pulmonary embolism and risk of stroke and embolism due to atrial fibrillation, Approved January 2015

Hematology
Natpara (parathyroid hormone) ; NPS Pharmaceuticals; For the control hypocalcemia in patients with hypoparathyroidism, Approved January 2015

Immunology
Cosentyx (secukinumab); Novartis; For the treatment of plaque psoriasis, Approved January 2015

Evotaz (atazanavir and cobicistat) ; Bristol-Myers Squibb; For the treatment of HIV-1 infection, Approved January 2015

Prezcobix (darunavir and cobicistat); Janssen; For the treatment of HIV-1 infection, Approved January 2015

Infections and Infectious Diseases
Bexsero (Meningococcal Group B Vaccine); Novartis; For the treatment of invasive meningococcal disease caused by serogroup B, Approved January 2015

Evotaz (atazanavir and cobicistat) ; Bristol-Myers Squibb; For the treatment of HIV-1 infection, Approved January 2015

Prezcobix (darunavir and cobicistat); Janssen; For the treatment of HIV-1 infection, Approved January 2015

Neurology
Duopa (carbidopa and levodopa) enteral suspension ; Abbvie; For the treatment of motor fluctuations in patients with advanced Parkinson's disease, Approved January 2015

Rytary (carbidopa and levodopa) extended-release capsules; Impax Labs; For the treatment of Parkinson's disease, Approved January 2015

Obstetrics/Gynecology (Women¡¯s Health)
Ibrance (palbociclib); Pfizer; For the treatment of ER-positive, HER2-negative breast cancer, Approved February 2015

Oncology
Ibrance (palbociclib); Pfizer; For the treatment of ER-positive, HER2-negative breast cancer, Approved February 2015

Pediatrics/Neonatology
Bexsero (Meningococcal Group B Vaccine); Novartis; For the treatment of invasive meningococcal disease caused by serogroup B, Approved January 2015

Vaccines
Bexsero (Meningococcal Group B Vaccine); Novartis; For the treatment of invasive meningococcal disease caused by serogroup B, Approved January 2015
»Ø¸´´ËÂ¥

» ÊÕ¼±¾ÌûµÄÌÔÌûר¼­ÍƼö

ò§çïҩѧ żµÄ

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

¾ý×Ó²ØÆ÷ÓÚÉí£¬´ýʱ¶ø¶¯£¡
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

³ô±¿±¿

ľ³æ (ÕýʽдÊÖ)

°ô°ô

[ ·¢×ÔÊÖ»ú°æ http://muchong.com/3g ]
2Â¥2015-02-10 19:46:47
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÁèÓîÀ׳Ø

³¬¼¶°æÖ÷ (ÎÄѧ̩¶·)

Сľ³æ¿ÆÑдóʹ\(^o^)/~

ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

лл·ÖÏí\(^o^)/~
ÉÏÉÆÈôË®\(^o^)/~2025\(^o^)/~
3Â¥2015-02-11 08:30:25
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

myktt

ÖÁ×ðľ³æ (ÖøÃûдÊÖ)

º¢Ëûµù

лл£¬ÊÕµ½ÁË
ºÏ³ÉÀϰÖ
4Â¥2015-02-11 15:22:14
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

gatzz_0827

½ð³æ (ÕýʽдÊÖ)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Ibrance (palbociclib); Pfizer; For the treatment of ER-positive, HER2-negative breast cancer, Approved February 2015
´óÅúÇÀ·Â¹«Ë¾¿ªÊ¼¼¦¶³ÁË
5Â¥2015-02-12 09:17:37
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Áîºü³å?ÛСÐÜ

ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)

ħµÀÊ¥¾ý

ÒýÓûØÌû:
5Â¥: Originally posted by gatzz_0827 at 2015-02-12 09:17:37
Ibrance (palbociclib); Pfizer; For the treatment of ER-positive, HER2-negative breast cancer, Approved February 2015
´óÅúÇÀ·Â¹«Ë¾¿ªÊ¼¼¦¶³ÁË

¶¯×÷¿ìµÄ£¬Ó¦¸ÃÔÚÈýÆÚÁÙ´²Ê±¾Í¿ª¶¯ÁË
¾ý×Ó²ØÆ÷ÓÚÉí£¬´ýʱ¶ø¶¯£¡
6Â¥2015-02-12 09:40:05
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ Áîºü³å?ÛСÐÜ µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 295Çóµ÷¼Á +8 19171856320 2026-02-28 8/400 2026-03-02 11:19 by yuchj
[¿¼ÑÐ] 0856²ÄÁÏÓ뻯¹¤£¬270Çóµ÷¼Á +8 YXCT 2026-03-01 9/450 2026-03-02 11:01 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] Ò»Ö¾Ô¸Ö£´ó²ÄÁÏѧ˶298·Ö£¬Çóµ÷¼Á +6 wsl111 2026-03-01 6/300 2026-03-02 11:00 by ydudjddnd
[¿¼ÑÐ] ²ÄÁÏѧ˶318Çóµ÷¼Á +7 February_Feb 2026-03-01 7/350 2026-03-02 10:57 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] ²ÄÁÏÀàÇóµ÷¼Á +11 wana_kiko 2026-02-28 14/700 2026-03-02 08:46 by ´ÏÃ÷µÄ´óËÉÊó
[¿¼ÑÐ] ¸ß·Ö×Ó»¯Ñ§ÓëÎïÀíµ÷¼Á +6 ºÃºÃºÃ1233 2026-02-28 13/650 2026-03-02 07:27 by ºÃºÃºÃ1233
[¿¼ÑÐ] 292Çóµ÷¼Á +6 yhk_819 2026-02-28 6/300 2026-03-01 23:23 by ÏòÉϵÄÅÖ¶«
[¿¼ÑÐ] 265·ÖÇóµ÷¼Á²»µ÷רҵºÍѧУÓÐÐÐѧÉÏ¾Í +6 ÀñÌö¡Õæ258 2026-02-28 8/400 2026-03-01 22:50 by jian_
[»ù½ðÉêÇë] ³É¹ûϵͳ·ÃÎÊÁ¿´ó£¬ÇëһСʱºóÔÙ³¢ÊÔ¡£---NSFCɶʱºòºÃŶ£¬ÒѾ­Á½ÌìÕâÑùÁË +4 NSFC2026ÎÒÀ´ÁË 2026-02-28 4/200 2026-03-01 22:37 by ÌúÃÅ˨
[¿¼ÑÐ] 275Çóµ÷¼Á +3 Ã÷Ô¶Çóѧ 2026-03-01 3/150 2026-03-01 22:29 by Áõ±ø
[¿¼ÑÐ] 299Çóµ÷¼Á +3 YÄ«Ã÷ÆåÃîY 2026-02-28 5/250 2026-03-01 21:01 by tangxiaotian
[¿¼ÑÐ] 306·Ö²ÄÁϵ÷¼Á +4 chuanzhu´¨Öò 2026-03-01 5/250 2026-03-01 19:48 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 328Çóµ÷¼Á +3 aaadim 2026-03-01 5/250 2026-03-01 17:29 by njzyff
[¿¼ÑÐ] ¿ÎÌâ×é½ÓÊÕ²ÄÁÏÀàµ÷¼ÁÑо¿Éú +3 gaoxiaoniuma 2026-02-28 4/200 2026-03-01 14:30 by jjjÈý¿ç
[¿¼ÑÐ] 298Çóµ÷¼Á +9 È˼äΨÄãÊÇÇå»¶ 2026-02-28 12/600 2026-03-01 14:23 by Ducount.Y
[¿¼ÑÐ] 302²ÄÁϹ¤³ÌÇóµ÷¼Á +4 Doleres 2026-03-01 5/250 2026-03-01 11:52 by liqiongjy
[ÂÛÎÄͶ¸å] ÇóÖúcoordination chemistry reviews µÄд×÷Ä£°å 10+3 ljplijiapeng 2026-02-27 4/200 2026-03-01 09:07 by babero
[ÂÛÎÄͶ¸å] Optics lettersͶ¸å±»¾ÜÇóÖú 30+3 luckyry 2026-02-26 4/200 2026-03-01 09:06 by babero
[»ù½ðÉêÇë] ÃæÉÏÄ£°å¸Ä²»ÁËÒ³±ß¾à°É£¿ +5 ieewxg 2026-02-25 6/300 2026-03-01 00:10 by addressing
[˶²©¼ÒÔ°] ¡¾²©Ê¿ÕÐÉú¡¿Ì«Ô­Àí¹¤´óѧ2026»¯¹¤²©Ê¿ +4 N1ce_try 2026-02-24 8/400 2026-02-26 08:40 by N1ce_try
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û